Amy Wakeham - Resmed VP Communications
Insider
Amy Wakeham is VP Communications of Resmed Inc DRC
| Phone | 858 836 5000 |
| Web | https://www.resmed.com |
Resmed Management Efficiency
The company has return on total asset (ROA) of 0.1155 % which means that it generated a profit of $0.1155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2352 %, meaning that it generated $0.2352 on every $100 dollars invested by stockholders. Resmed's management efficiency ratios could be used to measure how well Resmed manages its routine affairs as well as how well it operates its assets and liabilities.Resmed Inc DRC has accumulated 765.33 M in total debt with debt to equity ratio (D/E) of 0.27, which may suggest the company is not taking enough advantage from borrowing. Resmed Inc DRC has a current ratio of 2.74, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Resmed until it has trouble settling it off, either with new capital or with free cash flow. So, Resmed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Resmed Inc DRC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Resmed to invest in growth at high rates of return. When we think about Resmed's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Nicole Priest | Merit Medical Systems | N/A | |
| Brian Bonnell | ICU Medical | 51 | |
| Juan Aragon | The Cooper Companies, | N/A | |
| B Owens | AptarGroup | 66 | |
| Rajwant Sodhi | ResMed Inc | 46 | |
| Richard Luzzi | West Pharmaceutical Services | 72 | |
| Brian Capone | Embecta Corp | 49 | |
| CPA Parra | Merit Medical Systems | 47 | |
| John Knorpp | Merit Medical Systems | N/A | |
| Kimberly MacKay | West Pharmaceutical Services | 58 | |
| Warner H | The Cooper Companies, | 56 | |
| Heidi Tlili | AptarGroup | 49 | |
| Constance Bienfait | ResMed Inc | N/A | |
| James Borzi | Baxter International | 61 | |
| Neil Peterson | Merit Medical Systems | 58 | |
| Mark Drury | The Cooper Companies, | 45 | |
| Jacqueline Kunzler | Baxter International | 55 | |
| Ajay Kumar | Embecta Corp | 53 | |
| Kimberly Chainey | AptarGroup | 48 | |
| Molly Joseph | West Pharmaceutical Services | 46 | |
| A Bender | The Cooper Companies, | 79 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 |
Resmed Inc DRC Leadership Team
Elected by the shareholders, the Resmed's board of directors comprises two types of representatives: Resmed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Resmed. The board's role is to monitor Resmed's management team and ensure that shareholders' interests are well served. Resmed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Resmed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Wakeham, VP Communications | ||
| Brett Sandercock, CFO and Principal Accounting Officer | ||
| BE MBA, CEO Director | ||
| Robert Douglas, Pres and COO | ||
| Vered Keisar, Chief Officer | ||
| David Pendarvis, Chief Admin. Officer, Global General Counsel and Secretary | ||
| AM AM, Founder Chairman | ||
| Kaushik Ghoshal, Pres Bus | ||
| Constance Bienfait, Director Relations | ||
| Urvashi Tyagi, Chief Officer |
Resmed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Resmed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 33.08 B | |||
| Shares Outstanding | 1.47 B | |||
| Shares Owned By Institutions | 7.93 % | |||
| Price To Earning | 28.58 X | |||
| Price To Book | 9.54 X | |||
| Price To Sales | 9.04 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Resmed Pink Sheet
If you are still planning to invest in Resmed Inc DRC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Resmed's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |